Pune, India -- (SBWIRE) -- 03/27/2018 -- The Global LDL Test Market is expected to grow with a CAGR of approximately 5.5% during the forecast period from 2017-2023.

Low density lipoproteins (LDL) is also known as bad cholesterol. As high levels of LDL may result in build-up of cholesterol which may lead to stroke or even a heart attack. The five major types of lipoproteins are very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), intermediate-density lipoprotein (IDL), high-density lipoprotein (HDL) and chylomicrons. The function of lipoprotein is to transport fats molecules such as cholesterol and triglycerides through the blood to the organs of the body. The cases of heart failure were estimated about 30% across the globe. Coronary heart disease mortality rate was about 60% in 2016 as per OMICS international.

According to Centres for Disease Control and Prevention (CDC), in 2015 merely 71 million people are estimated to suffer from high low-density lipoprotein (LDL), or bad cholesterol level in U.S. Every 2 out of every 3 adults with LDL cholesterol has the condition under control.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4215 .

Global LDL Test Market – Competitive Analysis

F. Hoffmann-La Roche Ltd (Switzerland), Sekisui Diagnostics (U.S.), Express Biotech International (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Randox Laboratories Ltd (Ireland), Reckon Diagnostics (India), Quest Diagnostics Incorporated (U.S.), DiaSys Diagnostics India Private Limited (India), Eurofins Scientific (Germany), Kopibeskyttet Unilabs Labhåndbok (UK), Atlas Medical Uk (UK), Eurolyser Diagnostica GmbH (Germany), Laboratory Corporation of America, Diazyme Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and others are some of the prominent players at the forefront of competition in the global LDL test market and are profiled in MRFR Analysis.

The market is highly fragmented. Moreover the major players are adopting various strategies such as joint ventures, market initiatives, agreements, high expense on research and development, partnerships, acquisitions, and others for expanding and increase their footprints in this market.

Segments:

The global LDL test market has been segmented on the basis of types, components, applications and end users.

Based on types, the market has been segmented into LDL-C, LDL-P, LDL-B and others.

Based on components, the market has been segmented into devices, kits & reagents and others. Devices is further sub-segmented into syringes & needles, spectrophotometers and others. And kits & reagents is further sub-segmented into toxicity assays kit, blood chemistry assays kit, cytotoxicity assays kit.

Based on application, the market has been segmented as atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/4215 .

Based on the end users, the market has been segmented as hospitals and clinics, pharmaceutical and biotechnological companies and others.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3 Research Methodology

3.1 Primary Research Methodology

3.2 Secondary Research Methodology

3.3 Market Share Analysis

3.4 Market Pricing Approach

4 Market Factor Analysis

…TOC Continued

Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/4215 .


Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.